AKESF
Price
$19.58
Change
+$1.02 (+5.50%)
Updated
Jul 24 closing price
Capitalization
17.05B
INBX
Price
$23.03
Change
-$0.04 (-0.17%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
334.1M
24 days until earnings call
Interact to see
Advertisement

AKESF vs INBX

Header iconAKESF vs INBX Comparison
Open Charts AKESF vs INBXBanner chart's image
AKESO
Price$19.58
Change+$1.02 (+5.50%)
Volume$6.81K
Capitalization17.05B
Inhibrx Biosciences
Price$23.03
Change-$0.04 (-0.17%)
Volume$11.36K
Capitalization334.1M
AKESF vs INBX Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. INBX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Buy and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AKESF: $19.38 vs. INBX: $23.08)
Brand notoriety: AKESF and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 59% vs. INBX: 183%
Market capitalization -- AKESF: $17.05B vs. INBX: $334.1M
AKESF [@Biotechnology] is valued at $17.05B. INBX’s [@Biotechnology] market capitalization is $334.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than AKESF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 4 bullish TA indicator(s).

  • AKESF’s TA Score: 4 bullish, 4 bearish.
  • INBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AKESF is a better buy in the short-term than INBX.

Price Growth

AKESF (@Biotechnology) experienced а +7.43% price change this week, while INBX (@Biotechnology) price change was -5.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($17B) has a higher market cap than INBX($334M). AKESF has higher P/E ratio than INBX: AKESF (25.37) vs INBX (0.19). AKESF YTD gains are higher at: 176.786 vs. INBX (49.870).
AKESFINBXAKESF / INBX
Capitalization17B334M5,090%
EBITDAN/A1.73B-
Gain YTD176.78649.870354%
P/E Ratio25.370.1913,084%
RevenueN/A200K-
Total CashN/A217M-
Total DebtN/A107M-
TECHNICAL ANALYSIS
Technical Analysis
AKESFINBX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
67%
Bearish Trend 26 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RWK122.731.02
+0.83%
Invesco S&P MidCap 400 Revenue ETF
VV293.961.09
+0.37%
Vanguard Large-Cap ETF
IBIC25.69-0.01
-0.06%
iShares iBonds Oct 2026 Term Tips ETF
FDIG39.34-0.32
-0.81%
Fidelity Crypto Industry&DgtlPymntsETF
SMDD13.96-0.36
-2.51%
ProShares UltraPro Short MidCap400

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
-1.05%
INBX - AKESF
45%
Loosely correlated
+0.04%
SMMT - AKESF
27%
Poorly correlated
+3.99%
NUVL - AKESF
25%
Poorly correlated
-0.82%
BNTX - AKESF
23%
Poorly correlated
+0.65%
CPMV - AKESF
22%
Poorly correlated
+25.37%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+0.04%
AXON - INBX
48%
Loosely correlated
+3.63%
AKESF - INBX
45%
Loosely correlated
-1.05%
COGT - INBX
41%
Loosely correlated
-0.98%
ACET - INBX
40%
Loosely correlated
-0.54%
SNTI - INBX
39%
Loosely correlated
-3.02%
More